Evaluation of systemic absorption and bronchodilator effect of glycopyrronium bromide delivered by nebulizer or a dry powder inhaler in subjects with chronic obstructive pulmonary disease

BACKGROUND: Effective bronchodilator therapy depends upon adequate drug deposition in the lung. COPD patients who are unable to administer medications efficiently with conventional inhalers may benefit from the use of a nebulizer device. The aim of this study was to evaluate the systemic bioavailabi...

Descripción completa

Detalles Bibliográficos
Autores principales: Leaker, Brian R., Singh, Dave, Nicholson, Grant C., Hezelova, Blanka, Goodin, Thomas, Ozol-Godfrey, Ayca, Galluppi, Gerald, Barnes, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599298/
https://www.ncbi.nlm.nih.gov/pubmed/31253162
http://dx.doi.org/10.1186/s12931-019-1113-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599298/
https://www.ncbi.nlm.nih.gov/pubmed/31253162
http://dx.doi.org/10.1186/s12931-019-1113-z

Ejemplares similares